Tagged: COVID-19

The Evolution of Third-Party Risk Management

Third-party risk management is a favorite topic for compliance professionals.  And for good reason.  Third parties create significant risks.  To state the obvious, companies have less control over third parties than employees. But for many reasons companies engage third parties as a more effective solution than hiring employees.  In this situation, risk multiplies exponentially. The third-party risk issue, however, has multiplied exponentially for a number...

Episode 197 — Review of LRN and NAVEX Global Compliance Surveys and Reports

LRN and NAVEX Global release two important annual surveys.  LRN issues a yearly report on ethics and compliance program effectiveness.  NAVEX Global issues an important annual report on incident management trends based on its large database of hotline data. In this Episode, Michael Volkov review these two reports and the important ethics and compliance trends.

Drug and Medical Device Fraud Risks Increase in Pandemic Era

The drug and medical device/testing industry is under significant pressure to develop new products to address the COVID-19 pandemic.  The federal government is increasing spending and support of drug and device companies in anticipation of developing a new vaccine, treatment products and testing.  As a result, pharmaceutical, medical device and diagnostic and laboratory tests will be subject to federal scrutiny and monitoring for proper use...

The Risk of “Price Gouging” in the New COVID-19 Pandemic Marketplace

The COVID-19 pandemic era has transformed the economy  with a new emphasis on health and safety related products (e.g., sanitizers, toilet paper, designated medical supplies).  Our economy has suffered severe disruptions to demand and supply of goods and services.  In this new economy, businesses face extraordinary risks of federal and state prosecution for price gouging. The federal price gouging law applies narrowly to critical items...

Webinar: COVID-19 — The New Compliance and Risk Framework

COVID-19 — The New Compliance and Risk Framework May 6, 2020, 12 Noon EST SIGN UP HERE The COVID-19 Pandemic has had a devastating impact on everyone around the globe, resulting in over 55,000 deaths in the United States. The global economy has suffered serious disruption and harm. The recovery path appears to be slow and there are increasing risks of a recurrence of the...

COVID-19 and Force Majure Contractual Provisions

It turns out law school was very helpful to practicing law – every first year law student is required to take a contract law class.  Now, lawyers are able to apply what they learned in the most unlikely of circumstances – the Covid-19 pandemic. Companies suffering from the shelter in place and business disruptions have to identify and assess liability under contracts with vendors, suppliers...

COVID-19: Supply Chain Risks Lessons

Companies are struggling.  Many have shut down.  Some are surviving from a remote workforce.  Some critical businesses – healthcare providers, food, pharmacies and essential services (e.g. utilities) – are continuing to operate.  Employers have given large numbers of raises and have to adapt to a new marketplace with COVID-19 risks and regulatory requirements.  Certain businesses are hiring large numbers of employees – Amazon, drug stores...

COVID-19: Important Changes to Employment Law

Congress recently enacted the Families First Coronavirus Response Act (“FFCRA”) (Copy Here), which included a number of important changes.  Given the disastrous impact of the pandemic on the workplace, businesses that are still operating have to adhere to health and safety requirements.  OSHA guidelines require companies to sanitize the workplace, and require employees to use protective equipment.  OSHA has released guidance on COVID-19 in the...

Episode 134: COVID-19 (Part II) — Business Response to Pandemic

COVID-19 has had a devastating impact.  The public health crisis has caused tragic human loss and is overwhelming the United States healthcare system.  Businesses have suffered along with the public. Business face real challenges managing the crisis, their respective supply chains and employees. In the second part of a two-part series, Mike Volkov reviews important business responses and strategies for coping with the pandemic.

Episode 133 — COVID-19 (Part I): Absence of Federal Leadership and Recent Congressional Actions

COVID-19 has had a devastating impact.  The public health crisis has caused tragic human loss and is overwhelming the United States healthcare system.  Businesses have suffered along with the public.   The lack of federal leadership has been glaring.  States and local governments are coping the best they can despite the obvious absence of federal leadership.  In this two-part episode, Mike Volkov examines the federal and...